Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Salvarx Group Plc LSE:SALV London Ordinary Share IM00BZ4SS228 ORD 2.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 4.50 0.00 0.00 0.00 0.00 - 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.0 -0.5 1.0 4.5 2

Salvarx Share Discussion Threads

Showing 326 to 347 of 500 messages
Chat Pages: 20  19  18  17  16  15  14  13  12  11  10  9  Older
DateSubjectAuthorDiscuss
13/9/2018
14:48
Seven separate sales of 713 shares each. This must be some kind of code !
dexdringle
12/9/2018
08:41
Portage website: "Toronto, Ontario, August 28, 2018 (PBT.U: CSE; PTGEF: OTC Markets) Portage Biotech Inc. ("Portage" or the "Company") wishes to announce that, further to its news release of August 14, 2018 announcing the proposed acquisition of SalvaRx Limited from SalvaRx Group plc, it has now submitted draft shareholder meeting materials to CSE for review. Until the meeting materials have been approved by CSE for distribution, however, trading in the shares of Portage will remain halted. Upon clearance of the meeting materials, a further announcement will be made regarding the meeting date and a trade resumption date" How long does it take the Canadian Stock Exchange to approve materials created to be used in a shareholder meeting? I fear this is all going to end in disappointment....
dexdringle
09/9/2018
21:44
....I'm sure it will (disappoint)....
dexdringle
09/9/2018
21:18
It's 20th October ladies and gentlemen. Let's hope Intensity don't disappoint. Fig.
fig1
07/9/2018
08:48
Is it "post something completely irrelevant" day ?
dexdringle
07/9/2018
08:40
htTps://twitter.com/Stockonomist/status/1037963927072788480?s=19
the stigologist
05/9/2018
16:39
"Crazy low valuation".....well only if the science works. Otherwise it is worth £0.....
dexdringle
03/9/2018
11:44
Crazy low valuation I still expect deal to be viewed positively in North America so the existing discount will simply become bigger and bigger
the stigologist
29/8/2018
01:36
hTtp://www.stockhouse.com/news/press-releases/2018/08/28/portage-provides-update-on-proposed-acquisition-of-salvarx
the stigologist
29/8/2018
01:35
Update re proposed disposal and demerger Further to the announcement of 14 August 2018 relating to the proposed disposal of the Company's 94.2 per cent. interest in its subsidiary SalvaRx Limited to Portage Biotech Inc. ("Portage"), the Company has been informed that the Portage shareholder circular has now been submitted to the Canadian Securities Exchange ("CSE") for review. Following completion of the CSE review, both Portage and the Company will publish their respective shareholder circulars and a further announcement will be made by the Company.
the stigologist
27/8/2018
09:14
If a startup company can be valued at $10 billion on just 40 patients data the potential for Intensity to be a $1 billion dollar company in the near future can't be dismissed. The Insiders clearly think we are onto something massive.
the stigologist
27/8/2018
09:12
These are mind boggling numbers... " The investor community is also optimistic about this sector with record amounts of venture money flowing into startups this past year. In fact, in February 2018, BMS recorded the largest upfront payment for a license in history. They paid US$3.6 billion for 35% of the profits on Nektar's immunotherapy after seeing data on approximately 40 patients."
the stigologist
26/8/2018
12:46
One does get the impression that ducks are being lined up in a row. Fig.
fig1
26/8/2018
11:30
Agree Stig. Intensity hasn’t tweeted since Dec 2017, now they tweet every day. Take the hint
jonesyboy 27
26/8/2018
02:03
In 5 years Intensity only ever tweeted 200 times up to August 20th (about 40 tweets a year, less than one a week) In the last week Intensity have tweeted about 10 tweets, including retweeting a tweet mentioning #SALV and they've hinted their next major Presentation of Data is due in October... The writing is pretty much on the wall for anybody with more than one braincell. SALV / Portage clean up September Intensity results October Intensity will be looking like a $1bn+ company SALV/Portage investors are going to clean up bigtime Mellon etc aren't in this for a minor £m here or there, they're going for the big one £100m+
the stigologist
26/8/2018
01:31
Great consolidation expect 100p+ soon
the stigologist
23/8/2018
10:34
Jonesy, Thanks for confirming Portage will be under the complete control of Mellon and Bailey. The shell will be able to sell Portage to pay off debt, admin costs with a bit of cash left over. It will need to do an RTO within 12 months (6 months before suspension and then 6 months until the listing is cancelled). Unless Eke has something lined up, and he may have one of his own businesses, that is quite a racy timeline given all the bureaucracy involved. Https://beta.companieshouse.gov.uk/officers/FXm-TSe6fKwCqaT3axE0iKP1SRQ/appointments Https://beta.companieshouse.gov.uk/officers/luGUWHkdxSTf3WWinrekk4ocTsQ/appointments Https://beta.companieshouse.gov.uk/officers/NuPbTd4OpHw9afEgQUUyJvRMz54/appointments Https://beta.companieshouse.gov.uk/officers/TxwouW_JrpHJOHXDpiwQk4uDdiA/appointments Https://beta.companieshouse.gov.uk/officers/Su6PT0JB0tBzDoYHJQJbVkNVLKY/appointments Https://beta.companieshouse.gov.uk/officers/009G8Gh1GpR45GPYOsbBlkSvuSI/appointments
sweet karolina
22/8/2018
18:14
Mellon & Bailey hold 40% portage pre-deal and will hold ~60% of portage post deal. With the Salv shell waiting with 60 million + portage shares. What will they use the shell for is the question....
jonesyboy 27
22/8/2018
14:40
Cudmore. Clown who posts on wrong thread. Filtered.
dexdringle
22/8/2018
13:43
As I said earlier!! IIP! https://twitter.com/nictrades/status/1032244070175911937?s=21
cudmore
22/8/2018
09:53
IIP about to take off. 30p short term easily here.
cudmore
22/8/2018
08:27
That is the problem with many new drugs, they pass stage 1, which shows they do no harm, they many get part way through stage 2 showing some benefits, but when they go up against existing drugs they often fail to show a clear efficacy advantage. Even then commercial success is not guaranteed as it all depends on whether NHS / Insurance companies are prepared to pay the extra for them. It will be interesting to read the valuation report, which gives a range of values using a variety of techniques, ultimately though it is a lot like waiting to see if your numbers come up in the lottery. I expect the valuation report will be made available here: Https://www.portagebiotech.com/investors/shareholder-circular.html
sweet karolina
Chat Pages: 20  19  18  17  16  15  14  13  12  11  10  9  Older
ADVFN Advertorial
Your Recent History
LSE
SALV
Salvarx
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200814 09:08:12